We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$1.44B
AUM Growth
-$332M
Cap. Flow
-$353M
Cap. Flow %
-24.46%
Top 10 Hldgs %
20.52%
Holding
396
New
136
Increased
45
Reduced
61
Closed
139

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.02%
2 Communication Services 10.27%
3 Industrials 7.77%
4 Technology 6.99%
5 Healthcare 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDFN
226
PUT
DELISTED
Redfin
RDFN
$450K 0.03%
25,000
-55,000
-69% -$1.05M
X
227
DELISTED
US Steel
X
$449K 0.03%
+29,305
New +$452K
BHVN
228
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$438K 0.03%
10,000
+931
+10% +$52.5K
CONE
229
DELISTED
CyrusOne Inc Common Stock
CONE
$413K 0.03%
+7,162
New +$420K
AEO icon
230
American Eagle Outfitters
AEO
$3.04B
$411K 0.03%
+24,332
New +$493K
FSLR icon
231
First Solar
FSLR
$21.8B
$405K 0.03%
+6,168
New +$371K
GRUB
232
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$395K 0.03%
+2,533
New +$345K
ACER
233
DELISTED
Acer Therapeutics Inc
ACER
$390K 0.03%
+100,001
New +$1.91M
GE icon
234
GE Aerospace
GE
$377B
$386K 0.03%
7,377
+4,487
+155% +$221K
GES
235
DELISTED
Guess Inc
GES
$381K 0.03%
+23,572
New +$408K
XLB icon
236
State Street Materials Select Sector SPDR ETF
XLB
$8.82B
$371K 0.03%
+12,668
New +$357K
STML
237
PUT
DELISTED
Stemline Therapeutics, Inc.
STML
$307K 0.02%
+20,000
New +$289K
SPCE icon
238
CALL
Virgin Galactic
SPCE
$320M
$298K 0.02%
11,239
+8,676
+339% +$1.79M
PLAY icon
239
Dave & Buster's
PLAY
$361M
$293K 0.02%
7,243
-136,781
-95% -$6.96M
INTC icon
240
Intel
INTC
$435B
$280K 0.02%
+5,858
New +$290K
BBBY
241
Bed Bath & Beyond
BBBY
$503M
$279K 0.02%
+27,291
New +$255K
FBRX icon
242
CALL
Forte Biosciences
FBRX
$1.57B
$266K 0.02%
+107
New +$317K
EQIX icon
243
Equinix
EQIX
$102B
$252K 0.02%
+500
New +$240K
AXSM icon
244
Axsome Therapeutics
AXSM
$12.1B
$249K 0.02%
9,678
-37,295
-79% -$748K
BKR icon
245
Baker Hughes
BKR
$58B
$238K 0.02%
+9,673
New +$233K
FOMX
246
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$238K 0.02%
100,000
-789,000
-89% -$2.36M
PLX icon
247
Protalix BioTherapeutics
PLX
$188M
$235K 0.02%
+50,000
New +$211K
UBER icon
248
Uber
UBER
$144B
$226K 0.02%
+4,876
New +$207K
TTSH
249
CALL
DELISTED
Tile Shop Holdings
TTSH
$200K 0.01%
+50,000
New +$238K
CRTO icon
250
Criteo
CRTO
$1.06B
$193K 0.01%
11,214
-2,845
-20% -$55.9K

Similar funds

J. Goldman & Co's Q2 2019 Portfolio in Review

As of Q2 2019, J. Goldman & Co held 396 positions worth $1.44B, down 19% from $1.77B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

J. Goldman & Co withdrew a net $353M in Q2 2019, closing 139 positions and reducing 61 holdings. Its most notable exit was Cognizant, an estimated $35.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, down from 16% a quarter earlier, followed by Communication Services and Industrials.

Against the trend, J. Goldman & Co opened a new position in Act II Global Acquisition Corp Unit worth $16M.

  • J. Goldman & Co's largest Q2 2019 buy was Act II Global Acquisition Corp Unit: 1,580,000 shares worth $16M.
  • J. Goldman & Co added most to Fidelity National Information Services in Q2 2019, an estimated $16.7M increase.
  • J. Goldman & Co's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $80.6M.
  • J. Goldman & Co fully exited Cognizant in Q2 2019, selling an estimated $35.7M.
  • J. Goldman & Co's ten largest holdings make up 21% of its $1.44B portfolio in Q2 2019.
  • J. Goldman & Co opened 136 new positions and closed 139 in Q2 2019.
  • J. Goldman & Co's portfolio value fell 19% quarter-over-quarter to $1.44B.

Based on J. Goldman & Co's 13F filing for Q2 2019, filed 14 Aug 2019.